EFMC-ASMC'17

Conferences > Upcoming events > EFMC-ASMC'17
Sunday August 27, 2017
09:30Excursion 1
14:00Registration
14:00Excursion 2
17:00Opening
Karin BRINER (NOVARTIS, Cambridge, United States)
Erick M. CARREIRA (ETH ZÜRICH / SPIROCHEM, Zürich, Switzerland)
17:15Opening Lecture
T01 - Next-Generation Small Molecule Therapeutics
James E BRADNER
(NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Cambridge, MA, United States)
18:30Welcome Reception
Monday August 28, 2017
Session chair
Erick M. CARREIRA
(ETH ZÜRICH / SPIROCHEM, Zürich, Switzerland)
08:30T02 - Controlling Biological Pathways With Photopharmacology
Dirk TRAUNER
(NEW YORK UNIVERSITY, New York, United States)
09:15T03 - Drugging the Undruggable
Mark BUNNAGE
(VERTEX PHARMACEUTICALS, Boston, United States)
10:00OC01 - Stereoselective Peptide Modifications – Efficient Tools for Natural Product and Drug Synthesis
Uli KAZMAIER
(SAARLAND UNIVERSITY, Saarbrücken, Germany)
10:15Coffee Break and Exhibition
10:45T04 - Bioinspired Asymmetric Catalysis
Helma WENNEMERS
(ETH ZURICH, Zürich, Switzerland)
11:30T05 - Strategies to Facilitate the Discovery of Novel CNS Positron Emission Tomography (PET) Ligands
Lei ZHANG
(PFIZER, Cambridge, United States)
12:15OC02 - Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6
Peter ETTMAYER
(BOEHRINGER-INGELHEIM, Vienna, Austria)
12:30Lunch and Exhibition
13:30Poster Session 1
Session chair
Thierry LANGER
(UNIVERSITY OF VIENNA, Vienna, Austria)
14:30T06 - Recent Advances in Methods Development and Applications
Gary A. MOLANDER
(UNIVERSITY OF PENNSYLVANIA, Philadelphia, United States)
15:15T07 - Beta-secretase Inhibitors as a Therapy for Alzheimer’s Disease – Where Are We Now?
Roland BÜRLI
(ASTRAZENECA, Cambridge, United Kingdom)
15:45OC03 - Mimicking Nature Complexity with 3D-Fragments Assembly
Hugues LEMOINE
(EDELRIS, LYON, France)
16:15Coffee Break and Exhibition
16:45PRIZE winner EFMC-YMCS 2016
OC04 - Development of Highly Selective and Reversible Diacylglycerol Lipase Inhibitors
Freek JANSSEN
(LEIDEN UNIVERSITY, Nijmegen, The Netherlands)
17:00T08 - Idea2Data: Augmenting Drug Discovery Efforts through Synthetic Reaction Data Mining and Automation
Christos A. NICOLAOU
(ELI LILLY, Indianapolis, United States)
17:45T09 - A RaPID Way to Discover Pseudo-natural Peptides for Therapeutic Uses
Hiroaki SUGA
(UNIVERSITY OF TOKYO, Tokyo, Japan)
18:30Closing of the day
Tuesday August 29, 2017
Session chair
Koen AUGUSTYNS
(UNIVERSITY OF ANTWERP, Antwerp, Belgium)
08:30T10 - Azidoperfluoroalkanes - Neglected, Stable and Useful Fluorinated Synthons
Petr BEIER
(ACADEMY OF SCIENCES OF THE CZECH REPUBLIC, Prague, Czech Republic)
09:15T11 - Antiviral Drug Design
Nicholas MEANWELL
(BRISTOL-MYERS SQUIBB, Wallingford, United States)
10:00OC05 - Discovery of RG7314, a Vasopressin 1a Receptor Antagonist for the Treatment of Social Communication Deficits in Autism Spectrum Disorders
Patrick SCHNIDER
(F. HOFFMANN-LA ROCHE, Basel, Switzerland)
10:15Coffee Break and Exhibition
10:45T12 - When Chemistry Asks Biological Questions: Total Synthesis on the Driving Seat
Nuno MAULIDE
(UNIVERSITY OF VIENNA, Vienna, Austria)
11:30T13 - Isosteric-Switch Strategies: New Concepts and Recent Advances
Thomas C. FESSARD
(SPIROCHEM AG, Zurich, Switzerland)
12:15OC06 - Expanding Screening Decks by Innovative MCR Scaffolds
Alexander DÖMLING
(UNIVERSITY OF GRONINGEN, Groningen, The Netherlands)
12:30Lunch and Exhibition
13:30Poster Session 2
Session chair
Gene VAISBERG
(CHEMBRIDGE CORPORATION, San Diego, United States)
14:30T14 - Iron(III)-Catalyzed Carbonyl-Olefin Metathesis
Corinna SCHINDLER
(UNIVERSITY OF MICHIGAN, Ann Arbor, United States)
15:15T15 - Ring Construction by Pd-catalyzed C(sp3)-H Activation
Olivier BAUDOIN
(UNIVERSITY OF BASEL, Basel, Switzerland)
16:00OC07 - The Discovery of Soluble Guanylate Cyclase Stimulators for the Treatment of Pulmonary Arterial Hypertension
Subharekha RAGHAVAN
(MSD, Kenilworth, New Jersey, United States)
16:15Coffee Break and Exhibition
16:45T16 - Merck Drug Discovery through Enabling Capabilities
Petr VACHAL
(MSD, Kenilworth, United States)
17:30T17 - Adventures in Catalysis: from Mechanisms to Applications
Franziska SCHOENEBECK
(RWTH AACHEN, Aachen, Germany)
18:15Closing of the day
Wednesday August 30, 2017
Session chair
Helma WENNEMERS
(ETH ZURICH, Zürich, Switzerland)
08:30T18 - Exploiting Physical Organic Principles in Reaction Design
Ryan GILMOUR
(UNIVERSITY OF MÜNSTER, Münster, Germany)
09:15T19 - Automation, Integration and Miniaturization In Drug Discovery Synthesis
Guido KOCH
(NOVARTIS PHARMA AG, Basel, Switzerland)
10:00OC08 - Exploring New Methods for Facile Synthesis of Some Biologically Interesting Molecules
Ming-Hua XU
(SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, Shanghai, China)
10:15Coffee Break and Exhibition
10:45T20 - Design and Evolution of New Biocatalysts for Organic Synthesis
Nicholas John TURNER
(UNIVERSITY OF MANCHESTER, Manchester, United Kingdom)
11:30T21 - With Asymmetric Hydrogenation towards a Scalable, Stereoselective Synthesis of Bitopertin
Michelangelo SCALONE
(F. HOFFMANN-LA ROCHE AG, Basel, Switzerland)
12:15OC09 - Development of Synthesis Strategies to DNA-Encoded Compound Libraries - of a Chemoresistant Sequence, and Micellar Nanoreactors
Andreas BRUNSCHWEIGER
(TU DORTMUND, Dortmund, Germany)
12:30Lunch and Exhibition
13:30Poster Session 3
Session chair
Yves P. AUBERSON
(NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland)
14:30T22 - Collaborative Academic/Industrial Research Under the Umbrella of the NSF Center for Selective C-H Functionalization
Huw DAVIES
( EMORY UNIVERSITY, Atlanta, United States)
15:15Roundtable discussion
16:15Coffee Break and Exhibition
16:45EFMC Prize for a Young Medicinal Chemist in Academia
OC10 - Nature-Derived Peptides as Pharmacological Tools to Design Novel Therapeutics
Christian W. GRUBER
(MEDICAL UNIVERSITY OF VIENNA, Vienna, Austria)
17:30EFMC Prize for a Young Medicinal Chemist in Industry:
OC11 - The Development of non-BET Bromodomain Chemical Probes
Phil HUMPHREYS
(GLAXOSMITHKLINE, Stevenage, United Kingdom)
17:45T23 - Strategies towards Increasing the 3-Dimensionality of the Medicinal Chemistry Design Space
Antonia F. STEPAN
(PFIZER, Cambridge, United States)
18:30Closing of the day
20:00Symposium banquet
Thursday August 31, 2017
Session chair
Karin BRINER
(NOVARTIS, Cambridge, United States)
08:30T24 - Synthetic, Mechanistic and Computational Studies on Reactions of Interest
Scott E. DENMARK
(UNIVERSITY OF ILLINOIS, Urbana, United States)
09:15T25 - More Options, More Complexity: Medicinal Chemistry Mastering Mixed Modalities
Werngard CZECHTIZKY
(SANOFI-AVENTIS DEUTSCHLAND GMBH, Frankfurt, Germany)
10:00OC12 - Discovery of UCB0942, the First Rationally Designed Antiepileptic Drug with a Dual Mechanism of Action for the Treatment of Drug-Resistant Epilepsy
Laurent PROVINS
(UCB, Braine-l'Alleud, Belgium)
10:15Coffee break and Exhibition
10:45T26 - DNA Repair Inhibition in Cancer Therapy: DNA-PK Inhibitor M3814
Thomas FUCHSS
(MERCK KGAA, Darmstadt, Germany)
11:30T27 - Late Stage 18F-Fluorination for PET Imaging
Véronique GOUVERNEUR
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)
12:15Closing remarks
12:30End of the Symposium

Copyright 2017 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys